Prodrugs of phosphates and phosphonates: Novel lipophilic α-acyloxyalkyl ester derivatives of phosphate- or phosphonate containing drugs masking the negative charges of these groups

European Journal of Pharmaceutical Sciences

Volumn 4, Issue 1, 1996, Pages 49-59

  Friis, Gitte Juel ^a   Bundgaard, Hans ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Hydrolysis; Phosphate; Phosphonate; Plasma; Prodrug; Acyloxyalkylester

Indexed keywords

ESTER DERIVATIVE; PHOSPHATE; PHOSPHONIC ACID DERIVATIVE; PRODRUG;

ARTICLE; DERIVATIZATION; DRUG DEGRADATION; DRUG HYDROLYSIS; DRUG SYNTHESIS; LIPOPHILICITY; PRIORITY JOURNAL;

EID: 0030029534     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-0987(95)00031-3     Document Type: Review

References (29)

1. Bauer, C.W. and Lasala, E.F. (1960) The preparation and the properties of an aspirin homolog β-(O-acetoxyphenyl)propionic acid. J. Am. Pharm. Assoc. 49, 48-53.
2. Bel'skii, V.E. (1977) Kinetics of the hydrolysis of phosphate esters. Russ. Chem. Rev. 46, 828-841.
3. Binderup, E. and Hansen, E.T. (1984) Chlorosulfates as reagents in the synthesis of carboxylic acid esters under phase-transfer conditions. Synth. Comm. 14, 857-864.
4. Björkroth, J-P., Pakkanen, T.A., Lindroos, J., Pohjala, E., Hanhijärvi, H., Laurén, L., Hannuniemi, R., Juhakoski, A., Kippo, K. and Kleimola, T. (1991) Comparative molecular field analysis of some clodronic acid esters. J. Med. Chem. 34, 2338-2343.
5. Bundgaard, H. (1985) Design of prodrugs: Bioreversible derivatives for various functional groups and chemical entities. In: Bundgaard, H. (Ed.), Design of Prodrugs. Elsevier, Amsterdam, pp. 70-74.
6. Cundy, K.C., Fishback, J.A., Shaw, J.-P., Lee, M.L., Soike, K.F., Visor, G.C. and Lee, W.A. (1994) Oral bioavailability of the antiretroviral agent 9-(2-phoshonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug Bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys. Pharm. Res. 11, 839-843.
7. Dardoize, F., Goasdoue, C., Gaosdoue, N., Laborit, H.M. and Topall, G. (1989) 4-Hydroxybutyric acid (and analogues) derivatives of D-glucosamin. Tetrahedron 45, 7783-7794.
8. Farquhar, D., Srivastva, D.N., Kuttesch, N.J. and Saunders, P.P. (1983) Biologically reversible phosphate-protective groups. J. Pharm. Sci. 72, 324-325.
9. Farrow, S.N., Jones, A.S., Kumar, A., Walker, R.T., Balzarini, J. and De Clercq, E. (1990) Synthesis and biological properties of the novel phosphotriesters: A new approach to the introduction of biologically active nucleotides into cells. J. Med. Chem. 33, 1400-1406.
10. Fleisch, H. (1991) Biphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone diseases (Review). Drugs 42, 919-944.
11. Freeman, S., Irwin, W.J., Mitchell, A.G., Nicholls, D. and Thomson, W. (1991) Bioreversible protection for the phospho group: chemical stability and bioactivation of di(4-acetoxybenzyl)methylphosphonate with carboxyesterase. J. Chem. Soc., Chem. Commun. 875-877.
12. Harned, H.S. and Hamer, W.J. (1933) The ionization constant of water in potassium chloride solution from electromotive forces of cells without liquid junctions. J. Am. Chem. Soc. 53, 2194-2206.
13. Hokin, L.E. and Dixon, J.F. (1993) The phosphoinositide signalling system. I. Historical background. II. Effects of lithium on the accumulation of second messenger inositol 1,4,5-triphosphate in the brain cortex slices. Prog. Brain. Res. 98, 309-315.
14. Iyer, R.P., Phillips, L.R., Biddle, J.A., Thakker, D.R. and Egan, W. (1989) Synthesis of acyloxyalkyl acylphosphonates as potential prodrugs of the antiviral, trisodium phosphonoformate (Foscarnet sodium). Tetrahedron Lett. 30, 7141-7144.
15. Krol, E.S., Davis, J.M. and Thatcher, G.R.J. (1991) Hydrolysis of phosphonoformate esters: product distribution and reactivity patterns. J. Chem. Soc., Chem. Commun. 118-119.
16. Krol, E.S. and Thatcher, G.R.J. (1993) Hydrolysis of phosphonoformate triesters: rate acceleration of a millionfold in nucleophilic substitution at phosphorus. J. Chem. Soc. Perkin Trans. 2, 793-794.
17. McGuigan, C., Pathirana, R.N., Mahmood, N., Devine, K.G. and Hay, A.J. (1992) Aryl derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT. Antiviral Res. 17, 311-321.
18. Mitchell, A.G., Nicholls, D., Walker, I., Irwin, W.J. and Freeman, S. (1991) Prodrugs of phosphoformate: products, kinetics and mechanisms of the hydrolysis of Dibenzyl (Methoxycarbonyl)phosphonate. J. Chem. Soc. Perkin. Soc. 2, 1297-1303.
19. Mitchell, A.G., Nicholls, D., Irwin, W.J. and Freeman, S. (1992) Prodrugs of phosphoformate: the effect of parasubstituents on the products, kinetics and mechanism of hydrolysis of dibenzyl (methoxycarbonyl)phosphate. J. Chem. Soc. Perkin Trans. 2, 1145-1150.
20. Nielsen, N.M. and Bundgaard. H. (1987) Prodrugs as drug delivery systems. 68. Chemical and plasma-catalyzed hydrolysis of various esters of benzoic acid: a reference system for designing prodrug esters of carboxylic acids. Int. J. Pharm. 39, 75-85.
21. Norén, J.O., Helgstrand, E., Johansson, N.G., Misiorny, A. and Stening, G. (1983) Synthesis of esters of phosphonoformic acid and their antiherpes activity. J. Med. Chem. 26, 264-270.
22. Öberg, B. (1989) Antiviral effects of phosphonoformate (PFA, Foscarnet sodium). Pharmacol. Ther. 40, 213-285.
23. Papapoulos, S.E., Landman, J.O., Bijvoet. O.L.M., Löwik, C.W.G.M., Valkema, R., Pauwels, E.K.J. and Vermeij, P. (1992) The use of bisphophonates in the treatment of osteoporosis. Bone 13, S41-S49.
24. Robins, R. K. (1984) The potential of nucleotide analogs as inhibitors of retroviruses and tumors. Pharm. Res. 1. 11-18.
25. Schultz, H.W. (1963) Synthesis and antifungal activity of anilides of salicylic acid and O-cumaric acid. J. Pharm. Sci. 52, 503-505.
26. Schultz, C. and Tsien, R.Y. (1992) Membrane-permeant derivatives of inositol polyphosphates applied to REF-52 fibroblasts. FASEB 6, A1924.
27. Srivastva, D.M. and Farquhar, D. (1984) Bioreversible phosphate protective groups: synthesis and stability of model acyloxymethyl phosphates. Bioorg. Chem. 12, 118-129.
28. Starrett, J.E., Tortolani, D.R., Hitchcock, M.J.M., Martin, J.C. and Mansuri, M.M. (1992) Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine. Antiviral Res. 19, 267-273,
29. Walker, I., Nicholls, D., Irwin, W.J. and Freeman S. (1994) Drug delivery via the active transporter at the blood-brain barrier: affinity of a prodrug of phosphonoformate for the large amino acid transporter. Int. J. Pharm. 104, 157-167.